Lifeward Ltd. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Lifeward Ltd. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.03M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $25.66M | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | $13.85M | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | $5.51M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $5.97M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $4.39M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $4.87M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $6.55M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $7.75M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $5.87M | Feb 8, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.40M | Mar 18, 2026 |
| FY2024 | Dec 31, 2024 | $1.70M | Mar 7, 2025 |
| FY2023 | Dec 31, 2023 | $435.0K | Feb 27, 2024 |
| FY2022 | Dec 31, 2022 | $352.0K | Feb 23, 2023 |
| FY2021 | Dec 31, 2021 | $432.0K | Feb 24, 2022 |
| FY2020 | Dec 31, 2020 | $330.0K | Feb 18, 2021 |
| FY2018 | Dec 31, 2017 | $135.0K | Feb 8, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.43M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $8.22M | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | $4.45M | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | $1.91M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $2.90M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $2.19M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $2.73M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $2.83M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $3.10M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $736.0K | Feb 8, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($19.91M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | ($28.94M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | ($22.13M) | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | ($19.57M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | ($12.74M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($12.98M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | ($15.55M) | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | ($21.68M) | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | ($24.72M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | ($32.50M) | Feb 8, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($19.67M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | ($29.35M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | ($23.61M) | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | ($19.10M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | ($12.66M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($12.00M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | ($14.05M) | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | ($19.21M) | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | ($21.99M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | ($30.44M) | Feb 8, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.25M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $4.63M | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | $4.15M | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | $4.03M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $2.94M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $3.46M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $5.35M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $7.35M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $6.04M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $9.03M | Feb 8, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($16.83M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | ($21.72M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | ($20.67M) | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | ($17.89M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | ($11.47M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($12.59M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | ($14.82M) | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | ($14.77M) | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | ($22.46M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | ($26.75M) | Feb 8, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.0K | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | $81.0K | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | $25.0K | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $47.0K | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $73.0K | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $22.0K | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $13.0K | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $21.0K | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $452.0K | Feb 8, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.90M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $30.49M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $63.19M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $74.24M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $94.75M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $28.07M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $24.37M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $14.96M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $22.86M | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | $31.76M | Mar 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.49M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $11.64M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $16.68M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $6.07M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $5.37M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $6.29M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $13.59M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $13.02M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $19.16M | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | $23.50M | Mar 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.41M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $18.85M | Mar 18, 2026 |
| FY2025 | Dec 31, 2023 | $46.51M | Mar 18, 2026 |
| FY2025 | Dec 31, 2022 | $68.17M | Mar 18, 2026 |
| FY2024 | Dec 31, 2021 | $89.38M | Mar 7, 2025 |
| FY2023 | Dec 31, 2020 | $21.77M | Feb 27, 2024 |
| FY2022 | Dec 31, 2019 | $10.78M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $1.95M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | $3.71M | Feb 18, 2021 |
| FY2019 | Dec 31, 2016 | $8.26M | Feb 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.76M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $7.54M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $7.54M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Feb 27, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($284.74M) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | ($264.83M) | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | ($235.88M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | ($213.75M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | ($194.18M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($181.45M) | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | ($168.47M) | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | ($152.92M) | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($131.22M) | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | ($106.49M) | Mar 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.17M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | $6.75M | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | $28.08M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $67.90M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $88.34M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $20.35M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $16.25M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $9.55M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $14.57M | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | $23.68M | Mar 8, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (17) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | (39) | Mar 18, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Feb 27, 2024 |
| FY2025 | Dec 31, 2023 | (31) | Mar 18, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 23, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (17) | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | (39) | Mar 18, 2026 |
| FY2023 | Dec 31, 2023 | 0 | Feb 27, 2024 |
| FY2025 | Dec 31, 2023 | (31) | Mar 18, 2026 |
| FY2023 | Dec 31, 2022 | 0 | Feb 27, 2024 |
| FY2024 | Dec 31, 2022 | (2) | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 23, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.52M | Mar 18, 2026 |
| FY2025 | Dec 31, 2024 | 733,966 | Mar 18, 2026 |
| FY2024 | Dec 31, 2023 | 8.59M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | 60.09M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 62.48M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 25.33M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 7.32M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 2.81M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 30.00M | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | 16.34M | Mar 8, 2018 |